Datamation content and product recommendations are editorially independent. We may make money when you click on links to our partners. Learn More.
Sinking its teeth deeper into the health care industry, IBM this week agreed to let Mayo Clinic use its Blue Gene supercomputer to research diseases.
The goal is to tap into the abundance of new data to foster medical breakthroughs, according to a statement. Financial terms of the pact were not made public, but IBM and the Mayo Clinic said they would spend ”millions of dollars per year in manpower, research and technology.”
The Mayo Clinic will be the first medical institution to use the power of Blue Gene, accessing specialized algorithms to perform molecular modeling. IBM and the clinic will also aim to map current and historical patient records and link them to new types of medical information.
”Our collaboration with IBM is focused on advancing the Mayo Clinic mission in the areas of patient care and research,” said Denis Cortese, M.D., president and CEO of Mayo Clinic. ”We are at a point with standards in technology and new genomic-based analytic techniques where we can achieve more in the next 10 years than we’ve achieved in the last 100, and we see in IBM a partner with a very unique capacity to deliver expertise and innovation.”
IBM and Mayo Clinic have already integrated 4.4 million patient records into a unified system, making it easier for physicians and researchers to call up info.
Going forward, both Big Blue and Mayo will integrate genomic and proteomic data with clinical records and public databases for use by physicians. The companies will also use Blue Gene to compare patient data to the data of other patients with similar disease characteristics.
For example, a doctor might be able to pinpoint the exact location of a patient’s cancer, as well as its gene characteristics, and make a prognostication based on the outcomes of therapy in the last 500 patients with similar cancer.
The multi-billion-dollar medical field is a lucrative one for IBM and other high-tech companies, which are all jockeying for position in the world’s largest life sciences companies.
IBM has locked down the Mayo Clinic since 2001 and Blue Gene, one of the company’s most popular supercomputers, has been used by several government organizations for research. Last November, IBM introduced a smaller version of Blue Gene.
This article was first published on internetnews.com.
RELATED NEWS AND ANALYSIS
-
Ethics and Artificial Intelligence: Driving Greater Equality
FEATURE |  By James Maguire,
December 16, 2020
-
AI vs. Machine Learning vs. Deep Learning
FEATURE |  By Cynthia Harvey,
December 11, 2020
-
Huawei’s AI Update: Things Are Moving Faster Than We Think
FEATURE |  By Rob Enderle,
December 04, 2020
-
Keeping Machine Learning Algorithms Honest in the ‘Ethics-First’ Era
ARTIFICIAL INTELLIGENCE |  By Guest Author,
November 18, 2020
-
Key Trends in Chatbots and RPA
FEATURE |  By Guest Author,
November 10, 2020
-
Top 10 AIOps Companies
FEATURE |  By Samuel Greengard,
November 05, 2020
-
What is Text Analysis?
ARTIFICIAL INTELLIGENCE |  By Guest Author,
November 02, 2020
-
How Intel’s Work With Autonomous Cars Could Redefine General Purpose AI
ARTIFICIAL INTELLIGENCE |  By Rob Enderle,
October 29, 2020
-
Dell Technologies World: Weaving Together Human And Machine Interaction For AI And Robotics
ARTIFICIAL INTELLIGENCE |  By Rob Enderle,
October 23, 2020
-
The Super Moderator, or How IBM Project Debater Could Save Social Media
FEATURE |  By Rob Enderle,
October 16, 2020
-
Top 10 Chatbot Platforms
FEATURE |  By Cynthia Harvey,
October 07, 2020
-
Finding a Career Path in AI
ARTIFICIAL INTELLIGENCE |  By Guest Author,
October 05, 2020
-
CIOs Discuss the Promise of AI and Data Science
FEATURE |  By Guest Author,
September 25, 2020
-
Microsoft Is Building An AI Product That Could Predict The Future
FEATURE |  By Rob Enderle,
September 25, 2020
-
Top 10 Machine Learning Companies 2021
FEATURE |  By Cynthia Harvey,
September 22, 2020
-
NVIDIA and ARM: Massively Changing The AI Landscape
ARTIFICIAL INTELLIGENCE |  By Rob Enderle,
September 18, 2020
-
Continuous Intelligence: Expert Discussion [Video and Podcast]
ARTIFICIAL INTELLIGENCE |  By James Maguire,
September 14, 2020
-
Artificial Intelligence: Governance and Ethics [Video]
ARTIFICIAL INTELLIGENCE |  By James Maguire,
September 13, 2020
-
IBM Watson At The US Open: Showcasing The Power Of A Mature Enterprise-Class AI
FEATURE |  By Rob Enderle,
September 11, 2020
-
Artificial Intelligence: Perception vs. Reality
FEATURE |  By James Maguire,
September 09, 2020